Japanese Encephalitis News and Research

RSS

Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.

China places third purchase order for H1N1 vaccine with Sinovac Biotech

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has received its third purchase order for its H1N1 vaccine, PANFLU.1, from China's Ministry of Industry and Information Technology for the national stockpiling plan.

27 Oct 2009

News outlets examine challenges with expanding global child immunization campaigns

Wednesday's release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don't get the recommended first-year vaccination.

23 Oct 2009

Research finds 50 million people vaccinated against zoonotic brain infection

Research at the University of Liverpool has supported the vaccination of more than 50 million people against a zoonotic brain infection that affects thousands of children across Asia every year.

7 Oct 2009

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for infectious diseases prevalent in emerging economies.

6 Oct 2009

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Sinovac Biotech Ltd. announced today positive top-line results from the completed clinical trial for its internally-developed H1N1 vaccine. The clinical data unblinding conference was held in Beijing on the afternoon of August 17, 2009. Notably, Sinovac is the first company worldwide to complete clinical trials for the H1N1 vaccine.

19 Aug 2009

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell AG (VSE: ICLL) today announced that the U.S. Food and Drug Administration (FDA) approved IXIARO(R), a new vaccine for the prevention of Japanese Encephalitis (JE).

30 Mar 2009

FDA approves IXIARO for Japanese encephalitis

The U.S. Food and Drug Administration has approved IXIARO, a vaccine to prevent Japanese encephalitis (JE) which is caused by a mosquito-transmitted virus found mainly in Asia. IXIARO will be the only vaccine for JE available in the United States.

30 Mar 2009

Japanese encephalitis damages the brain in two ways

Japanese encephalitis (JE), commonly known as brain fever, is one of the prevalent mosquito-borne encephalitis in India and entire South East (SE) Asia.

8 Jul 2008

New generation of insect repellents in the pipeline

The next generation of insect repellents could be in the pipeline with research from the U.S. suggesting seven possibilities.

27 May 2008

Minocycline antibiotic may prevent Japanese encephalitis

Two researchers from National Brain Research Center (NBRC) suggest that a common antibiotic called minocycline may prevent children from death due to Japanese encephalitis (JE), or commonly known as brain fever.

20 Feb 2008

A look at China's most innovative health biotechnology companies

Government funds innovation but venture capital needed; Wary investors 'need to be shown the exits'; Returning 'sea turtles' bring expertise, international credibility

8 Jan 2008

Researchers breach blood-brain barrier to deliver therapy

A major obstacle in the treatment of infections and other diseases of the brain is the blood-brain barrier, which prevents systemically delivered therapeutic drugs from reaching the brain.

19 Jun 2007

Global resurgence in zoonotic viral diseases

Doctors and veterinarians need to work together to tackle the increasing global threat of zoonotic viral diseases spread by non-human vertebrate hosts - including dogs, cattle, chickens and mosquitoes - according to a review in the November issue of Journal of Internal Medicine.

8 Nov 2006

Japanese Encephalitis News and Research

Further Reading

China places third purchase order for H1N1 vaccine with Sinovac Biotech

News outlets examine challenges with expanding global child immunization campaigns

Research finds 50 million people vaccinated against zoonotic brain infection

Inviragen, SingVax merge their complementary vaccine pipelines

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

FDA approves IXIARO for Japanese encephalitis

Japanese encephalitis damages the brain in two ways

New generation of insect repellents in the pipeline

Minocycline antibiotic may prevent Japanese encephalitis

A look at China's most innovative health biotechnology companies

Researchers breach blood-brain barrier to deliver therapy

Global resurgence in zoonotic viral diseases

740,000 vaccines urgently needed to control outbreak of Japanese encephalitis

West Nile virus DNA vaccine shows promise in phase 1 trial

Japanese encephalitis in Bali widespread

Single-dose of Japanese encephalitis vaccine protects children for over a year

Flaviviruses immune system defenses in different ways depending on whether they are transmitted by mosquitoes or ticks

Tourists to India need vaccination against Japanese encephalitis

Over 200 dead as Japanese encephalitis spreads further in India

Michael Stryker

The past, present and future of automation and digitalization in the life sciences laboratory

Arxspan BioDrive: A Versatile Solution for Molecular Biology

Latest News